Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
0.8117
+0.0091 (1.13%)
At close: Sep 11, 2026, 4:00 PM EDT
0.8220
+0.0103 (1.27%)
Pre-market: Sep 14, 2026, 4:31 AM EDT
Tempest Therapeutics Market Cap
Tempest Therapeutics has a market cap or net worth of $12.97 million as of September 11, 2026. Its market cap has decreased by -72.19% in one year.
Market Cap
12.97M
Enterprise Value
19.75M
1-Year Change
-72.19%
Ranking
Category
Stock Price
$0.81
ChartMarket Cap Chart
Since June 28, 2021, Tempest Therapeutics's market cap has decreased from $88.65M to $12.97M, a decrease of -85.37%. That is a compound annual growth rate of -30.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 12.97M | -8.28% |
| Dec 31, 2025 | 14.14M | -61.17% |
| Dec 31, 2024 | 36.42M | -57.00% |
| Dec 29, 2023 | 84.69M | 600.22% |
| Dec 30, 2022 | 12.09M | -66.85% |
| Dec 31, 2021 | 36.49M | -58.84% |
| Jun 28, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Moleculin Biotech | 13.93M |
| Quoin Pharmaceuticals | 13.64M |
| CalciMedica | 13.52M |
| SeaStar Medical Holding | 13.35M |
| Intensity Therapeutics | 13.12M |
| Adial Pharmaceuticals | 12.87M |
| NeuroSense Therapeutics | 12.84M |
| Aspire Biopharma Holdings | 12.71M |